The Global Interdependence Center – Solve Long Covid Initiative Program Series: Session VI: Long COVID Technology
Date: Tuesday, December 20, 2022
Complimentary video replay is available.
Event Detail
The Global Interdependence Center – Solve Long Covid Initiative Program Series: Session VI: Long COVID Technology
On Tuesday, December 20, the Global Interdependence Center, in partnership with the Solve Long Covid Initiative, will conclude its year-long program series on exploring the pandemic’s long-term healthcare, policy, and economic impact, specifically the implications of long-haul COVID or long COVID.
We invite you to register for our final webinar on how technology has played a role in the research, treatment, and future prospects of Long COVID. Join leading experts for a discussion on Long COVID and the intersection and application of technology to this growing field.
Throughout the year, GIC and SLCI will bring together world-class immunologists, medical experts, policymakers, and economists to explore critical insights into defining, diagnosing, optimizing treatments, and healthcare policies for long COVID and analyzing its impact on U.S. and global labor markets.
About the David R. Kotok Global Healthcare Series
GIC launched the David R. Kotok Global Healthcare Series in 2020; a virtual program series focused on the roles health and healthcare policy play in the interdependent global community. As a part of the series, the GIC has launched the “Analyzing Pandemics: Economic and Policy Impacts” executive briefings to explore the 100-year global pandemic event. Past briefings focused on the disease and the cure, COVID-19’s impact on food supply chains, artificial intelligence, climate change, and higher education.
In 2021, David Kotok and the Solve Long COVID Initiative offered a new gift to the GIC for funding, sponsorship, and logistical support for the Long COVID Program Series. The series serves as a neutral forum to elevate, vet, and share information about changing interdependencies caused by Long COVID’s impact on medical research, health care policy, fiscal policy, monetary policy, finance, trade, politics, and culture.
About the Solve Long Covid Initiative
The Solve Long Covid Initiative represents a collection of new and expanded programs in research, advocacy, and education that will improve outcomes for the millions suffering from post-infection diseases. Based on more than 30 years of research and advocacy experience advancing the understanding of post-infection diseases, the Solve Long Covid Initiative takes a strategic approach to integrating pre-pandemic and post-pandemic knowledge and community insights. Our work in the post-infection disease space has allowed us to create connections and build partnerships with researchers, clinicians, patients, government, and industry leaders.
Event Location
Speakers
Miguel Antonatos, MD
Physician Founder, Text2MDDr. Miguel Antonatos completed his medical school at Universidad Autonoma de Guadalajara in Guadalajara, Mexico and completed his residency at Morristown Memorial Hospital in Morristown NJ, an affiliate of The Mount Sinai Hospital and Icahn School of Medicine at Mount Sinai in NYC.
Harry Leeming
Founder and CEO, VisibleFounder and CEO of Visible, an activity tracking platform for Long Covid and ME/CFS. I have lived experience of Long Covid and previously worked at early-stage technology start-ups and as a Formula 1 engineer.
Lisa McIntire Shaw
Founding Partner of Cygnus Asset Management, LLCLisa McIntire Shaw is a founding partner of Cygnus Asset Management, LLC based in Charlotte, NC. She has more than 30 years of experience in the financial arena. Her areas of special interest include international markets; charitable trusts; strategic wealth preservation; and domestic, corporate, government and municipal bonds.
Amy Proal, Ph.D.
Microbiologist/Research Team Coordinator, PolyBio Research FoundationDr. Proal is a microbiologist who studies the molecular mechanisms by which bacterial, fungal and viral pathogens dysregulate human gene expression, immunity and metabolism. Her work further examines how dysbiosis of the human microbiome and/or the human virome can contribute to chronic inflammatory disease processes.
Andrew Rosenberg
Founder and CEO, Responsum HealthAndrew Rosenberg is a highly respected health policy expert and innovator, having founded Responsum Health, a groundbreaking patient-focused IT startup, and co-founded Thorn Run Partners (in 2010), a leading Washington, DC-based government relations firm.
Emily Taylor
Vice President of Advocacy and Engagement, Solve M.E.Emily Taylor is the Director of Advocacy and Engagement for Solve M.E. She brings to the organization over fifteen years of policy, organization, and advocacy experience in both the non-profit and government sectors.
Partners
Sponsors
